Related references
Note: Only part of the references are listed.Influence of Preformed Antibodies in Liver Transplantation
Isabel Legaz et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Tolerance studies in liver transplantation: are we fooling ourselves?
Lillian Tran et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2020)
Immunosuppression in liver transplant
Tommaso Di Maira et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2020)
De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody-mediated rejection after liver transplantation - a retrospective study
Barbora Kovandova et al.
TRANSPLANT INTERNATIONAL (2020)
Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies
Anne Hoefer et al.
SCIENTIFIC REPORTS (2020)
Prevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant Recipients
Vadim Jucaud et al.
HEPATOLOGY (2019)
Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience
Narendra Singh Choudhary et al.
CLINICAL TRANSPLANTATION (2018)
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients
Michael Charlton et al.
TRANSPLANTATION (2018)
2018 Annual Report of the European Liver Transplant Registry (ELTR)-50-year evolution of liver transplantation
Rene Adam et al.
TRANSPLANT INTERNATIONAL (2018)
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants
Sandy Feng et al.
GASTROENTEROLOGY (2018)
Five-Year Histological and Serological Follow-up of Operationally Tolerant Pediatric Liver Transplant Recipients Enrolled in WISP-R
Sandy Feng et al.
HEPATOLOGY (2017)
Basiliximab application on liver recipients: a meta-analysis of randomized controlled trials
Guo-Qing Zhang et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2017)
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group
James M. Neuberger et al.
TRANSPLANTATION (2017)
Can immunosuppression be stopped after liver transplantation?
Pierre-Alain Clavien et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Liver Retransplantation How Much Is Too Much?
Jennifer Berumen et al.
CLINICS IN LIVER DISEASE (2017)
Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts
J. G. O'Leary et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejectio
A. J. Demetris et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
EASL Clinical Practice Guidelines: Liver transplantation
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2016)
Identification of Bile Duct Paucity in Alagille Syndrome: Using CK7 and EMA Immunohistochemistry as a Reliable Panel for Accurate Diagnosis
Haley K. Herman et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2016)
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation
Merce Brunet et al.
THERAPEUTIC DRUG MONITORING (2016)
Prognostic factors for the evolution and reversibility of chronic rejection in pediatric liver transplantation
Ana Cristina Aoun Tannuri et al.
CLINICS (2016)
Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study
P. Trunecka et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Doppler Ultrasound and Transient Elastography in Liver Transplant Patients for Noninvasive Evaluation of Liver Fibrosis in Comparison with Histology: A Prospective Observational Study
H. H. Lutz et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy
Manuel Rodriguez-Peralvarez et al.
TRANSPLANT INTERNATIONAL (2015)
Outcome and Technical Aspects of Liver Retransplantation: Analysis of 25-Year Experience in a Single Major Center
H. Kim et al.
TRANSPLANTATION PROCEEDINGS (2015)
Hypothermic Oxygenated Perfusion (HOPE) Downregulates the Immune Response in a Rat Model of Liver Transplantation
Andrea Schlegel et al.
ANNALS OF SURGERY (2014)
Hepatic Retransplant What Have We Learned?
William H. Kitchens et al.
CLINICS IN LIVER DISEASE (2014)
De NovoDonor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients
H. Kaneku et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Prospective Multicenter Clinical Trial of Immunosuppressive Drug Withdrawal in Stable Adult Liver Transplant Recipients
Carlos Benitez et al.
HEPATOLOGY (2013)
Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors
Louise Barbier et al.
JOURNAL OF HEPATOLOGY (2013)
Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children
Stacey M. Pollock-BarZiv et al.
PEDIATRIC TRANSPLANTATION (2010)
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression - Long-term follow-up and evaluation of features for histopathological staging
K Blakolmer et al.
TRANSPLANTATION (2000)
Share Paper
